From an uneducated position, as far as i can tell, all phases must have a minimum time frame from start to finish of each phase.
That would make the most sense to me as to why they are doing so many phase 1 trials….not to mention they are still trying to assess R327 for its limitations.
if they cannot find a ceiling on its possibilities, how to put a price/value on it?
Ann: MCRI Pilot Study- Positive Efficacy Data for Lung Infections, page-9
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.005(1.67%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 29.5¢ | 29.5¢ | $2.899K | 9.826K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 88074 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 11274 | 2 |
View Market Depth
| Last trade - 09.59am 23/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |